ArticleJAMA oncology2021

Inserting Ensartinib Into the Starting Lineup for ALK-Rearranged Lung Cancer-A Likely Limited Role on a Deep Bench.

Ibiayi Dagogo-JackPubMed ↗Publisher ↗

No numbers read from the abstract.